| REVIEW ARTICLE |
|
| Year : 2020 | Volume
: 37
| Issue : 4 | Page : 155-163 |
|
|
Neuroinflammation in Alzheimer's disease continuum
Aslihan Taskiran-Sag1, Müge Yemişçi2
1 Department of Neurology, Faculty of Medicine, TOBB ETU, Ankara, Turkey
2 Institute of Neurological Sciences and Psychiatry; Department of Neurology, Faculty of Medicine, Hacettepe University; Neuroscience and Neurotechnology Center of Excellence (NÖROM), Ankara, Turkey
Correspondence Address:
Aslihan Taskiran-Sag
Department of Neurology, Faculty of Medicine, TOBB ETU, Ankara
Turkey
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/nsn.nsn_190_20
|
|
|
Aging population brings an ever-increasing global burden of dementia, and Alzheimer's disease (AD) is the most frequent type worldwide. Many years of research have introduced characteristic cerebral histopathological and molecular changes in this disease. However, all attempts to establish an effective treatment have failed. In this review, we aim to address the basic evidence regarding the role of inflammatory mediators in AD and their link to the other pathogenetic pathways. Novel findings based on advanced biotechnology and bioinformatics are covered briefly, as well.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
